World Investment Advisors LLC acquired a new stake in DocuSign, Inc. (NASDAQ:DOCU – Free Report) in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 37,274 shares of the company’s stock, valued at approximately $2,314,000.
Other large investors have also added to or reduced their stakes in the company. Inspire Investing LLC acquired a new position in DocuSign in the 3rd quarter valued at approximately $911,000. Charles Schwab Investment Management Inc. lifted its holdings in shares of DocuSign by 1.2% during the third quarter. Charles Schwab Investment Management Inc. now owns 1,328,355 shares of the company’s stock worth $82,478,000 after purchasing an additional 16,014 shares during the period. International Assets Investment Management LLC grew its stake in shares of DocuSign by 5,660.8% in the third quarter. International Assets Investment Management LLC now owns 438,914 shares of the company’s stock worth $27,252,000 after purchasing an additional 431,295 shares during the last quarter. Quantinno Capital Management LP increased its holdings in DocuSign by 39.5% in the third quarter. Quantinno Capital Management LP now owns 201,546 shares of the company’s stock valued at $12,514,000 after purchasing an additional 57,104 shares during the period. Finally, Robeco Institutional Asset Management B.V. raised its position in DocuSign by 7.1% during the 3rd quarter. Robeco Institutional Asset Management B.V. now owns 1,296,517 shares of the company’s stock worth $80,501,000 after purchasing an additional 85,987 shares during the last quarter. Institutional investors own 77.64% of the company’s stock.
DocuSign Trading Down 0.0 %
NASDAQ:DOCU opened at $94.48 on Friday. DocuSign, Inc. has a 12 month low of $48.70 and a 12 month high of $107.86. The stock has a market capitalization of $19.09 billion, a price-to-earnings ratio of 19.48, a PEG ratio of 8.72 and a beta of 0.92. The firm has a fifty day simple moving average of $78.04 and a two-hundred day simple moving average of $63.38.
Insider Transactions at DocuSign
Wall Street Analysts Forecast Growth
Several brokerages have recently weighed in on DOCU. Piper Sandler increased their price target on DocuSign from $60.00 to $90.00 and gave the company a “neutral” rating in a research note on Friday, December 6th. UBS Group increased their target price on shares of DocuSign from $60.00 to $100.00 and gave the company a “neutral” rating in a research report on Friday, December 6th. Hsbc Global Res upgraded shares of DocuSign to a “moderate sell” rating in a report on Friday, December 6th. Jefferies Financial Group upped their price objective on shares of DocuSign from $80.00 to $95.00 and gave the company a “buy” rating in a research note on Tuesday, December 3rd. Finally, HSBC reissued a “reduce” rating on shares of DocuSign in a research note on Friday, December 6th. Three research analysts have rated the stock with a sell rating, seven have issued a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $92.45.
View Our Latest Analysis on DocuSign
About DocuSign
DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.
Further Reading
- Five stocks we like better than DocuSign
- 3 Grocery Stocks That Are Proving They Are Still Essential
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- What Are Dividend Challengers?
- Texas Instruments: The Old-School Tech Titan Still Delivering
- What is a Secondary Public Offering? What Investors Need to Know
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Want to see what other hedge funds are holding DOCU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DocuSign, Inc. (NASDAQ:DOCU – Free Report).
Receive News & Ratings for DocuSign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocuSign and related companies with MarketBeat.com's FREE daily email newsletter.